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Effects of Rheumatoid Sera on Fibroblast Proliferation 
and Hyaluronic Acid Synthesis 
Rheumatoid serum depresses synovial fi- 
broblast proliferation in uitro and tends 
to enhance the rate of hyaluronic acid 
formed per cellular unit. Quantitatively, 
the observed effects are not large, are 
apparently not disease specific, and not 
HE rheumatoid inflammatory process T is characterized by uncontrolled con- 
nective tissue cell proliferation, overproduc- 
tion of specialized cell products, such as 
hyaluronic acid, colonization of affected 
tissues by various types of “inflammatory 
cells,” and alterations in the microvascula- 
ture. Once established, this complex process 
is “self-perpetuating” and leads to destruc- 
tion of capsular structures, cartilage, and 
bone with consequent impairment of artic- 
ular function. To identify and measure the 
important interrelationships in the rheuma- 
toid granuloma we have employed cell cul- 
ture techniques which permit intensive 
study of isolated segments of the problem 
in a simplified system. 
There is little literature dealing with the 
consequences of incorporating rheumatoid 
sera into nutrient medium to support hu- 
mean articular cells in uitro. One study con- 
cluded that the ability of synovial cells 
to spread on glass in tissue culture was 
inhibited by human serum, and that rheu- 
related to the titer of rheumatoid factor 
as measured by latex fixation. An im- 
proved method for measuring acid muco- 
polysaccharide in tissue culture medium 
is described. 
matoid serum was si@cantly more active 
in this respect than was normal serum.l 
This inhibitory phenomenon was obliter- 
ated in both normal and rheumatoid sera 
by heat inactivation at 56 C for 30 minutes. 
Another report concluded that rheumatoid 
serum did not influence the intrinsic viscos- 
ity of hyaluronic acid synthesized by syn- 
ovial tissue cultures derived from patients 
with rheumatoid arthritis and degenerative 
joint disease, but the point in the culture 
growth cycle when measurements were 
made in this study would not have been 
conducive to demonstrating serum-induced 
changes of intrinsic viscosity.2 
Earlier studies in this laboratory lead 
us to suggest that connective tissue cells 
derived from normal and rheumatoid syn- 
ovinl membrane exhibited measurable dif- 
ferences in function, differences which 
were transferable from one generation of 
cells to the next.“ This report deals with 
one element in a general study of connec- 
tive tissue cell function in rheumatic dis- 
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eases, that is: the regulatory influence of 
humoral (serum) factors on synovial con- 
nective tissue cells of rheumatoid and non- 
rheumatoid origin. In particular, the study 
is addressed to the possibility that factors 
in sera from patients with rheumatoid ar- 
thritis may modify functional activities of 
human articular connective tissue cells in 
ways which may be measured quantitative- 
ly in uitro. Cellular proliferative rate, hyal- 
uronic acid synthesis rate and the molecular 
weight of culture-produced hyaluronate 
were measured and compared in cultures 
supported by normal and rheumatoid sera. 
METHODS 
Procedures used for establishing, propagating, 
and subculturing cell strains from normal and 
pathologic synovial tissue were outlined in earlier 
publications.4~6~6 Enumeration and sizing of tryp- 
sin dispersed cells were carried out with a Coulter 
Model B cell counter. Sera were harvested from 
Mood samples which had clotted overnight at 
6 C. Erythrocytes were removed by centrifugation 
at  3000 rpm, 6 C. Sterilization was accomplished 
by vacuum filtration through a No. 6 Seitz pad 
at  6 C. Heat inactivation, when indicated, was 
carried out a t  52 C for 30 minutes. Tissue culture 
medium was composed of synthetic medium 
1066* (80 per cent), fetal calf serum" (10 per 
"Grand Island Biological Company, Grand 
Island, N. Y. 
cent), and hnman serum (10 per cent), supple- 
mented with L-glutamine and 100 pg./ml. of 
penicillin G and streptomycin. 
Hyaluronic acid (HA) in culture media was 
measured by a new procedure which is more ac- 
curate, more sensitive and far less time-consuming 
than our previous method.? Our current method is 
outlined in detail: 
Alcohol precipitation. Two ml. of medium 
sample is transferred to a 15 ml. Corex tube and 
8 ml. of absolute ethanol is added and mixed 
thoroughly (Vortex). Let this mixture stand for 
1 hour a t  room temperature and mix 2 or 3 times 
during this interval. Centrifuge the sample for 
10 minutes a t  12,000 rpm (25-27 C), decant siiper- 
natant fluid and save precipitate. 
Lipid extraction. Add 3 ml. of acetone to the 
precipitate, mix vigorously (Vortex) and allow to 
stand for 30 minutes at room temperature. Cen- 
trifuge sample as above, and decant as m i d i  
supernatant fluid as possible without breaking up 
the precipitate. The solvent remaining will evapo- 
rate overnight if tubes are left uncovered. 
Pronasei digestion. The protein-mucopolysac- 
charide precipitates should be thoroughly dry be- 
fore starting proteolytic digestion. To each sample 
add 2 ml. of pronase solution containing 1.0 mg. 
Pronase/2 ml. .05 M Tris buffer, pH 7.8-8.0. 
Incubate at 37 C for 1 hour with periodic mixing. 
The precipitate should be completely dissolved 
tpronase, a proteolytic enzyme formed by 
Streptomyces griseus was obtained from Califor- 
nia Corporation for Biochemical Research, LOS 
hgeles ,  Calif. 
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Table 2.-Efiects of Rheumatoid Sera on Cultured Fibroblasts 
Synovial Human Final HA/flask 
cell serum cell ct MCV final medium HA synthesis rate 
strain source x 106 ( P 3 )  change (rg.1 (pg/cell/day) 
MM-E* Normal 6.225 209 1 276 14.7 
MM-E RA-Pool 4.859 1734 576 39.5 
IP-G Normal 4.144 2193 139 11.2 
IP-G RA-Pool 4.256 2652 516 40.4 
*MM denotes the initials of the donor of the cell strain, and the “E” refers to the passage status of the 
strain. Thus, Milt-A would represent the f i s t  trypsin subculture from the explant. while MM-E was in its 
fifth passage. 
at the end of this period. If not, continue incu- 
bation. 
Cetylpyridinum chloride precipitation. Dilute 
the Pronase mixture with 5 ml. double distilled 
water and mix thoroughly. Add 0.2 ml of 5 per 
cent CPC in 0.2 M Na,SO, and allow to flocculate 
for either 1 hour at 37 C or overnight a t  room 
temperature. Collect the precipitate by centrifu- 
gation at 15,000 rpm for 10 minutes (25-27 C). 
This precipitate (CPC-HA complex) appears as 
a haze on the side of the tube and decantation 
of supernatant fluid should be performed care- 
fully. Dissolve CPC-HA precipitate in 2 ml. of 
2.0 hl, pH 7.0 sodium acetate by warming to 37 
C and mixing at intervals for 30 minutes. Use 
1.0 ml. of this preparation to analyze for uronic 
acid by a borate carbazole procedure.* 
Blanks consisting of unused media accompany 
each determination, and the optical density 
yielded by the blank media is subtracted from 
the sample absorbency before reading the corre- 
sponding pM value of the sample from the uronic 
acid standard curve. The pMoles of uronic acid 
determined represent that present in 1.0 ml. of 
the original media, and where the kind of muco- 
polysaccharide (MPS) contributing the uronic acid 
is known, the weight of the MPS/ml. is obtained 
by multiplying pM uronic acid times M.W. of 
Table Q.-Effects of Individual and Pooled Rheumatoid Sera on Cultured 
Human Fibroblasts 
Synovial Human Final HA/flask HA synthesis 
cell serum cell ct, MCV final medium rate Per cent 
strain source x 106 ($) change (pg.) (pg/cell/day) change 
MM-G Normal 4.662 2618 217 23.2 - 
MM-G RA-(NV)* 3.374 2312 192 28.4 + 22 
MM-G RA-(VB) 3.985 2312 201 25.3 + 9  
MM-G RA-(GS) 3.770 2448 217 28.8 +24 
MM-G RA-(LB) 3.075 2584 237 38.6 +66 
MM-G RA-(AR) 3.351 2686 238 35.5 +53 
IP-H Normal 3.189 2652 132 20.7 - 
IP-H RA- (AH) 2.909 2652 167 28.9 +40 
AM 11-G Normal 3.998 2143 161 20.3 
AM 11-G RA-(Pool) t 3.659 2253 192 26.4 + 30 
MaB-F Normal 4.081 2903 122 15.5 
MaB-F RA-(Pool) t 3.172 2923 125 19.7 +n 
- 
- 
*Parentheses include initials of individual serum donors. Sera labeled “normal” was from the same pool 
(3 normal donors) in each instance. Strain MM w a  from a patient with traumatic synovitis, AM I1 was 
from normal synovium, while I.P. and MaB were f roq  rheumatoid synovitis. 
tThe RA sera “pool” used on AM-I1 consisted of equal portions of sera L.B., G.S., V.B., and A.H. The 
RA sera pool for MaB consisted of equal portions of sera R.W. and T.M. 
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Table 4.-Egects of Individual and Pooled “Normal” Sera on Cultured Hunian Fibroblasts 
Synovial Human Final HA/flask HA synthesis 
Per cent cell serum cell ct MCV final medium rate 
strain source x 106 (p3) change (fig.) (pg/cell/day) change 
Pool 
WaK-H 182-H.I. * 4.615 2300 112.7 12.2 - 
Pool 
WaK-H A,B,AB-H.I. t 5.072 2333 124.7 12.6 + 3  
Pool 
Not H.I. 4.890 2200 132.7 13.6 +11 
WaK-H A-Not H.I. 5.026 2333 127.6 12.8 + 5  
WaK-H B-Not H.I. 5.466 2133 122.0 11.2 - 8  
WaK-H AB-Not H.I. 5.321 2133 135.3 12.7 + 4  
WaK-H A, B, AB- 
*Pool 182 consisted of 3 normal donors and H.I. means “heat inactivated a t  52”C, 30 min.” 
tThe designation A,B,AB of the individual donors refers to their blood types. Values in the table are the 
mean of 3 flasks. Variation in values within groups was of similar magnitude to the variation between group 
means noted above (i.e. 10% or less). 
the appropriate dissacharide. Mean recovery of 
HA added to culture media was 95.7 per cent 2 
standard deviation of 7.5 per cent in 71 consecu- 
tive trials. Good recoveries were obtained over 
the range of 1.0 to 100 pg./ml. of medium. Com- 
parison of media samples analyzed by the previous 
(dialysis) procedure7 and by the procedure out- 
lined here show good agreement. Viscometric 
measurement of hyaluronate molecular weight was 
performed with Ostwald viscometers, as described 
earlier.? 
Media from the cell cultures were tested for 
rheumatoid factor or rheumatoid factor-like ac- 
tivity by the multiple tube dilution technique 
described by Singer and P10tz.S End point titers 
were done beginning with the whole media which 
contained human serum in a dilution of 1:lO. 
Agglutination was read with the unaided eye im- 
mediately after incubation and centrifugation. 
None was refrigerated before reading. 
The pH of the diluted media, following addi- 
tion of the R.A. buffer, latex particles and plasma 
fraction 11, was determined to ensure that agglu- 
tination was not the result of variations in pH.* 
No significant variations from the pH of the RA 
buffer reagent were found. 
Cells from cultures were washed once with 
physiologic saline, centrifuged at  800 rpm and 
*Reagents used were Difco Bacto R.A. Buffer, 
Difco Bacto Latex, and Difco R.A. Plasma Frac- 
tion 11, purchased from Difco Laboratories, De- 
troit, Mich. 
resuspended in one ml. of 0.9 per cent saline so- 
lution. This suspension was then exposed to ultra- 
sonic vibration at 3 amp intensity for one minute 
using a Branson Sonifier.10 A portion of the soni- 
cated suspension was clarified by centrifugation 
for 10 minutes a t  2300 rpm in a table top centri- 
fuge. End point titers were performed by the 
method of Singer and Plotz, on the gross cell 
sonicates, and on the clear supernates obtained 
after centrifugation. Testing began at a dilution 
of 1:2 with careful monitoring of pH. Donors 
of rheumatoid sera were taking a variety of drugs 
and in most cases had a positive latex fixation test 
for rheumatoid factor (Table 1). 
RESULTS 
In a preliminary experiment pooled sera 
from 2 patients with rheumatoid arthritis 
(RA) were incorporated as the human se- 
rum component in media for cell strains 
derived from patients with traumatic syn- 
ovitis (MM)  and rheumatoid arthritis (I. 
P.). In view of the striking stimulation of 
hyaluronic acid elaborated by each strain 
(Table 2), a more detailed study was un- 
dertaken. Rheumatoid sera from individuals 
and from pools of 3 patients each were 
tested, using normal donor serum pools 
(3 persons) as controls. To minimize the 
effects of serum manipulation and avoid 
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Table 5.-Effects of lndividual Polycythentic Sera on Human Fibroblasts 
Synovial Human Final HA/flask HA synthesis 
cell serum cell ct final medium rate 
strain* source x 106 change bg.) (pg/cell/day) 
F2D-F Normal (87) 6.81 1 383 28.7 
F2D-F Normal (88) 5.519 367 33.9 
F2D-F Polycythemia (89) 2.030 103 23.8 
DES-F Polycythemia (104) 3.022 85 14.1 
DES-F Normal (1 15) 3.687 198 26.9 
DE-S-F Polycythemia (105) 2.482 194 39.1 t 
DE-S-F Polycythemia (106) 3.476 178 25.6 
EM-E Normal (130) 3.500 290 41.3 
EM-E Polycythemia (123) 2.986 282 51. l t  
EM-E Polycythemia (127) 3.371 178 26.6 
*Strain F2D was of rheumatoid origin, DE-S and EM were of normal origin. 
tSera 105 and 123 from patients with polycythemia rubra Vera altered culture performance much as did 
rheumatoid sera. 
masking heat-labile agents, no heat in- 
activation step was used in serum 
preparation. 
Both individual rheumatoid sera and 
pooled rheumatoid sera were less effective 
in supporting cell proliferation than was 
normal serum (Table 3). As recorded in 
Table 3, the defective growth-promoting 
capacity of rheumatoid serum was shown 
for two rheumatoid strains (I.P. and MaB), 
a “normal” strain (AM II), and a strain 
derived from a patient with traumatic syn- 
ovitis ( M M ) .  No consistent alterations in 
cell volume were noted in cultures nour- 
ished by rheumatoid serum. Hyaluronate 
synthesis, measured on a rate basis (pg/ 
cell/ day) , was increased in the presence 
of rheumatoid serum in all cases, the aver- 
age increase in apparent synthesis rate 
being 39 per cent. In 4 of the 8 compari- 
sons the increased HA synthesis rate by 
R.A.-sera treated cultures was largely ex- 
plained by decreased cell duplication in the 
face of absolute amounts of HA synthesis 
resembling controls, but four experiments 
exhibited both decreased culture growth 
and increased total HA formation. This lat- 
ter group demonstrated the largest percent- 
age increase in HA synthesis rate induced 
by RA-sera (30 to 66 per cent). 
A ,major concern in the interpretation 
of Table 3 revolves around the question 
of variability in culture response to any 
serum, whether from patients with rheu- 
matoid arthritis, from patients with other 
diseases, or from normal persons. The per- 
formance of a typical normal synovial cell 
strain in response to 6 different human 
serum preparations is illustrated in Table 
4. Growth, total HA synthesis and the HA 
synthesis rate agreed within about 10 per 
cent irrespective of serum preparation. This 
experiment suggests that neither pooling of 
normal sera nor heat inactivation affects 
the parameters measured. 
Our records indicate that HA synthesis 
rates measured at different times in the 
life history of a cell strain (i.e. at digerent 
in vitro ages and/or different transfer 
ages), and using different normal sera, may 
vary by 4 to 60 per cent from the mean 
performance value* for the strain. Even n 
~ ‘Mean performance value is used here to con- 
note the arithmetic average of all measurements 
of a given parameter made during the in uitro 
history of a cell strain prior to obvious senescent 
changes. 
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Table 6.-Rheumatoid Factor Titer in Culture Medium After Exposure to Fibroblasts 
Rheumatoid factor titer 
From cultures Synovial Human R.F. titer 
cell serum of unused 1st 2nd 3rd 
strain source medium change change change 
Traumatic 
synovitis 
MM-G Normal 0 0 0 0 
MM-G RA (NV) 5120 10240 10240 10240 
MM-G RA (VB) 20480 20480 20480 20480 
MM-G RA (GS) 10240 10240 10240 10240 
MM-G RA (LB) 640 1280 320 640 
MM-G RA (AR) 1280 1280 1280 1280 
Rheumatoid 
synovitis 
IP-H Normal 0 0 0 0 
IP-H RA (AH) 5120 5120 40960 40960 
single normal serum used as a medium 
component for a single cell strain at differ- 
ent transfer ages will sometimes yield indi- 
vidual HA synthesis rates deviating by 20 
to 40 per cent from the mean performance 
value for that strain. 
In the experiments recorded in Tables 
3 and 4, it is important to note that sera to 
be compared were used simultaneously on 
cells from the same stock culture popula- 
tions. Thus, the responding cells were of 
the same in dtro age and in the same 
biological condition at the onset of the test 
procedure. 
Increased HA synthesis rates in the pres- 
ence of rheumatoid serum usually were an 
arithmetic consequence of reduced cell di- 
vision associated with unchanged or slight- 
ly augmented total HA formation in n 
culture. Is such a pattern specific for rheu- 
matoid sera? Substances with general bio- 
logic toxicity might be expected to depress 
both cell division and specific macromolec- 
ular synthesis. Examination of Table 5 
shows 3 examples of sera from patients 
with polycythemia rubra Vera (sera 89, 
104 and 127) where such a general sup- 
pression of cellular activity was observed. 
On the other hand, polycythemic sera 105 
and 123 altered connective tissue cell func- 
tion in much the same fashion as did rheu- 
matoid sera. 
Drugs taken by patients are not likely 
to be responsible for the common serum 
effects, especially since aspirin was the only 
drug common to all donors of rheumatoid 
serum. Addition of salicylic acid in amounts 
equivalent to blood levels of 10 to 20 mg. 
per cent failed to affect proliferative rate 
or HA synthesis in pilot experiments. More- 
over, addition of hydroxychloroquin in me- 
dium concentrations of 1.0 to 3.0 pg./ml. 
did not alter fibroblast proliferation or HA 
formation. 
Rlieunaatoid Factor Measurements 
To examine rheumatoid factor in rela- 
tion to the observed alterations in cellular 
function, the end point titer of rheumatoid 
factor was measured in unused medium 
and medium removed at intervals from 
growing cultures during a 7-day growth 
cycle. We interpreted the serologic data 
(Table 6) to show that no significant alter- 
ation in titer of rheumatoid factor occurred 
as a result of 48-72 hours incubation at 37 
C with either “rheumatoid or non-rheu- 
matoid fibroblasts. In most cases the titers 
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Table 7.-Residual Rheumatoid Factor in 
Fibroblasts Exposed to Rheumatoid Sera 
Table 8.-Eflecf of Rheumatoid Serum on 
Intrinsic Viscosity of Culture Produced H.A. 
Cell strain 
MM (number 
of Cells X 106) 
14.0 X 106 
10.0 x 106 
11.9 x 106 
11.3 X 106 
9.2 X 106 
10.0 x 106  
R.F. titer 
Supernatant 
Donor of Whole (post 
RA sera sonicate centrifugation) 
Normal 1:2 0 
N.V. 1 :4 0 
V.B. 1 :4 0 
G.S. 1 :8 0 
L.B. 1 :2 0 
A.R. 1 :2 0 
were identical following incubation with 
cells, with an occasional one-tube variation. 
The increase in titer measured when rheu- 
matoid sera AH was placed on rheumatoid 
cells (I.P.) is of uncertain significance, al- 
though it may merely reflect an enhancing 
effect of mucopolysaccharide on rheumatoid 
factor measurement. 
Attempts to detect R.F. bound to cul- 
tured connective tissue cells failed to yield 
signifmnt titers. Neither whole cell soni- 
cates nor the supernatant fluid following 
centrifugation exhibited activity detected 
by latex fixation (Table 7). Not only were 
we unable to detect disappearance of R.F. 
activity from culture media, or binding to 
cells, but inspection of Tables 3 and 6 sug- 
gests that the degree of “stimulation” of 
HA synthesis rate may have been inversely 
related to the titer of rheumatoid factor. 
Intrinsic Viscosity Alterations in 
Hyaluronate 
Hyaluronic acid synthesized by human 
articular cells in culture exhibits variable 
intrinsic viscosity (a  parameter of molecu- 
lar weight) which is related to the stage of 
the culture growth cycle.7 Hyaluronate 
formed during the early (lag phase) por- 
tion of the growth cycle has the highest 
intrinsic viscosity, and this decreases mark- 
edly in medium changes corresponding to 
the growth and plateau portions of the 
[s] at 1st 
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*Indicates intrinsic viscosity measurements which 
were markcdly lowered in the presence of rheuma- 
toid sera when compared with the appropriate 
controls. 
cycle. As shown in Table 8, there was a 
tendency for cells supported by some rheu- 
matoid sera to form HA of lower molecular 
weight when compared with sister cultures 
nourished by normal sera. Cells of normal 
origin (AM-II), traumatic origin (MM) 
and from rheumatoid sources (I.P. and Ma 
B )  were similarly affected by sera from 
rheumatoid donors. In four instances the 
depression of molecular weight accompa- 
nied quantitative increases in total HA 
synthesis, but the experiment with strain 
MaB indicates that this was not a neces- 
sary relationship. Several rheumatoid sera 
had essentially no effect on the intrinsic 
viscosity of hyaluronate formed by cell 
strain MM. 
DISCUSSION 
The data suggest that rheumatoid sera 
tend to be relatively inhibitory to fibro- 
blastic proliferation in comparison with nor- 
mal sera prepared in the same fashion. I t  
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is clear that there is not a commensurate 
depression of hyaluronic acid synthesis; in 
fact, some sera support an absolute in- 
crease in the total amount of hyaluronic 
acid formed by a culture, and in virtually 
all cases there is an increase in the amount 
formed per individual cellular unit. In 4 
of 9, the RA sera appeared to be associ- 
ated with formation of smaller HA poly- 
mers. This change in metabolic activity 
does not appear to involve rheumatoid fac- 
tor, since we were unable to demonstrate 
loss of titer dependent upon incubation 
with the cells and equally unable to find 
agglutinating activity attached to the cellu- 
lar fraction. 
It would appear that there are humoral 
substances in the sera of patients with 
rheumatoid arthritis that are capable of 
modifying the proliferative and synthetic 
activities of human fibroblasts whether they 
be of normal or rheumatoid origin. Our 
data indicate that the factors in rheumatoid 
sera which alter connective tissue cell per- 
formance produce effects of very modest 
dimensions, and that these effects are not 
specific since they may be caused by poly- 
cythemic sera. 
SUMMARIO IN INTERLWGUA 
Sero rheumatoide deprime in vitro le proliferation de fibroblastos synovial e tende 
a intensificar le formation de acido hyaluronic in le cellulas individual. In terminos 
quantitative, le effectos observate non esseva grande. Apparentemente illos non es 
specific pro un morbo particular e non monstra un correlation con le titro de fac- 
tor rheumatoide mesurate per fixation a latex. Es describite un meliorate methodo 
pro mesurar mucopolysaccharida acide in medios histocultural. 
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